Global Induced Pluripotent Stem Cell (iPSC) Industry
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Viacyte Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Viacyte Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Viacyte Inc Today - Breaking & Trending Today
Analyzing CRISPR Therapeutics (NASDAQ:CRSP) and Vitro Diagnostics (OTCMKTS:VODG)
Vitro Diagnostics (OTCMKTS:VODG – Get Free Report) and CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Earnings & Valuation This table compares Vitro Diagnostics […]
Source: tickerreport.com
Vivani Medical : 2024 Investor Presentation -March 26, 2024 at 12:01 pm EDT
Disclaimers The following slides and any accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act...
Source: marketscreener.com
Global Human Embryonic Stem Cell Market Analysis 2024-2034:
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of sickle cell disease (SCD) in patients ...
Source: pharmiweb.com